US Stock Market Move | Q3 performance exceeds expectations, American Express Company (AXP.US) up over 4%.
On Friday, American Express (AXP.US) surged over 4%, closing at $337.67.
On Friday, American Express Company (AXP.US) rose more than 4%, reaching $337.67. On the news front, the company's third-quarter performance exceeded expectations. The financial report showed that American Express Company's Q3 revenue was $18.43 billion, up 10.8% year-on-year; earnings per share under non-GAAP were $4.14, higher than market expectations. The company reported third-quarter billings business volume (the transactions of credit cards and other products issued by American Express Company) at $421 billion. Analysts had previously predicted that the total billings of this New York-based company would reach $415.2 billion.
The company also raised the lower end of its full-year revenue guidance range, now forecasting revenue growth of 9% to 10%, compared to the market's general expectation of 8.95%; earnings per share are expected to be between $15.20 and $15.50, while the market's general expectation is $15.34. Previously, the company forecasted revenue growth of 8% to 10% and earnings per share of $15 to $15.50.
Related Articles

US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.

US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.

US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.

RECOMMEND